Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Dec;25(12):622-30.
doi: 10.1097/FPC.0000000000000170.

PharmGKB summary: succinylcholine pathway, pharmacokinetics/pharmacodynamics

Maria L Alvarellos  1 , Ellen M McDonagh, Sephalie Patel, Howard L McLeod, Russ B Altman, Teri E Klein
Affiliations
Review

PharmGKB summary: succinylcholine pathway, pharmacokinetics/pharmacodynamics

Maria L Alvarellos et al. Pharmacogenet Genomics. 2015 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: R.B.A and T.E.K are stockholders for Personalis Inc. H.L.M. is a founder and Principal at Ortelion and a stockholder for Cancer Genetics, Inc. For the remaining authors, there are no conflicts of interest.

Figures

Figure 1
Figure 1
Stylized cells depicting the metabolism and mechanism of action of succinylcholine. Note: the star symbol on the DHPR indicates that it has been activated by depolarization of the t-tubules. A fully interactive version is available at PharmGKB http://www.pharmgkb.org/pathway/PA166122732.
See this image and copyright information in PMC

References

    1. DailyMed-Anectine-Succinylcholine chloride injection, solution [http://www.dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=579ff759-3099-45f5-befe-c4b79106c87e]

    1. Appiah-Ankam J, Hunter JM. Pharmacology of neuromuscular blocking drugs. Continuing Education in Anaesthesia, Critical Care & Pain. 2004;4:2–7.
    1. Jonsson Fagerlund M, Dabrowski M, Eriksson LI. Pharmacological characteristics of the inhibition of nondepolarizing neuromuscular blocking agents at human adult muscle nicotinic acetylcholine receptor. Anesthesiology. 2009;110:1244–1252. - PubMed
    1. Albuquerque EX, Pereira EF, Alkondon M, Rogers SW. Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev. 2009;89:73–120. - PMC - PubMed
    1. Schaaf CP. Nicotinic acetylcholine receptors in human genetic disease. Genet Med. 2014;16:649–656. - PubMed

Publication types

MeSH terms

Supplementary concepts